Do not approve this release yet.

**Decision in scope:** launch of the production implementation copied from the selected HTML prototype.  
**Proposed outcome:** **Iterate** at G5 Implementation; G6 Live learning is not ready to proceed.  
**Required approver:** the named Product Owner or accountable launch owner, after the relevant specialist owners accept the evidence. I can recommend, but cannot grant launch approval.

The screenshots show only visual similarity. They do not demonstrate faithful integration. The reported differences affect four parts of the selected direction’s behavioral contract:

- keyboard order: accessibility and task completion;
- error recovery: content truth, safety, and recoverability;
- responsive behavior: use across required viewports and input modes;
- instrumentation: whether launch outcomes and harms can be detected and attributed.

On the information provided, the implementation delta is evidenced by a stakeholder report only (**E0**); there is no integrated production-like assurance (**E5**). Accessibility, content/error recovery, and measurement readiness are therefore at least **Not yet evidenced**. If the stated differences are confirmed against accepted requirements, implementation fidelity is **Fail**. Neither state is launch-passing, and schedule pressure cannot compensate for a hard-gate gap.

The shortest safe route is to:

1. Record each difference in the implementation delta log against the accepted requirement and selected direction.
2. Restore the contracted behavior, or obtain an explicit, documented design change approval; do not silently redefine the selected direction.
3. Verify the integrated build with keyboard-only operation, focus sequence, realistic error-and-recovery journeys, zoom/reflow and required breakpoints, and instrumentation event/consent checks.
4. Have accessibility, content/domain, engineering, and measurement owners sign their respective claims; preserve any dissent and residual-risk owner.
5. Return for the accountable human’s exact launch approval with evidence links and a rollback/harm-triage route.

A time-boxed delay is warranted here: releasing now would trade a visible schedule gain for unmeasured behavioral and accessibility risk.
